Hao Liu

机构：National University of Defense Technology, Xuzhou Medical College, Second People’s Hospital of Huai’an, Huaiyin Institute of Technology, Beihang University · ORCID：0000-0001-7175-9442

发表论文 139 篇 · 总被引 2010 次 · h-index 20

代表论文

• Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2 -Positive Locally Advanced Resectable Gastric Cancer (2025 · JAMA Oncology · 被引 19)
• Novel coumarin derivative SZC-6 as an allosteric activator of SIRT3 alleviates diabetic kidney disease via the SIRT3-Foxo3a signaling axis (2025 · Free Radical Biology and Medicine · 被引 13)
• Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 study (2025 · EClinicalMedicine · 被引 8)
• MSC ‐Derived Exosomal MiR‐127‐3p Alleviates Acute Kidney Ischemia–Reperfusion Injury via Suppressing ATG5 / ATG7 ‐Mediated Autophagy (2025 · Nephrology · 被引 7)
• Effect of carbon-based filler dimensions on the anti-corrosion performance for epoxy composite coating (2025 · Inorganic Chemistry Communications · 被引 5)
• SZC-6 Promotes Diabetic Wound Healing in Mice by Modulating M1/M2 Macrophage Ratio and Inhibiting MyD88/NF-χB Pathway (2025 · Research Square · 被引 4)